# Pharmacokinetics of Eplerenone Tablet

> **NCT02607657** · PHASE1 · WITHDRAWN · sponsor: **Biolab Sanus Farmaceutica**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Eplerenone 25 mg
- **DRUG:** Eplerenone 50 mg
- **DRUG:** Eplerenone 100 mg
- **DRUG:** Eplerenone 50 mg twice a day
- **DRUG:** Eplerenone 25 mg twice a day

## Key facts

- **NCT ID:** NCT02607657
- **Lead sponsor:** Biolab Sanus Farmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2016-10
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607657, "Pharmacokinetics of Eplerenone Tablet". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02607657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*